Evidence map›Paper›PMID 31736960›Full record

ArticleFrontiers in immunology2019

sumrep: A Summary Statistic Framework for Immune Receptor Repertoire Comparison and Model Validation.

Branden J Olson, Pejvak Moghimi, Chaim A Schramm, Anna Obraztsova, Duncan Ralph, Jason A Vander Heiden, Mikhail Shugay, Adrian J Shepherd, William Lees, Frederick A Matsen

Abstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. TCRCell · 2021
    Article
  13. Methods for sequence and structural analysis of B and T cell receptor repertoires.Computational and structural biotechnology journal · 2020
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Branden J OlsonFred Hutchinson Cancer Research Center, Seattle, WA, United States.
Pejvak MoghimiDepartment of Biological Sciences, Institute of Structural and Molecular Biology, Birkbeck, University of London, London, United Kingdom.
Chaim A SchrammVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Anna ObraztsovaCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Duncan RalphFred Hutchinson Cancer Research Center, Seattle, WA, United States.
Jason A Vander HeidenDepartment of Bioinformatics and Computational Biology, Genentech, Inc., South San Francisco, CA, United States.
Mikhail ShugayCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russia.
Adrian J ShepherdDepartment of Biological Sciences, Institute of Structural and Molecular Biology, Birkbeck, University of London, London, United Kingdom.
William LeesDepartment of Biological Sciences, Institute of Structural and Molecular Biology, Birkbeck, University of London, London, United Kingdom.
Frederick A MatsenFred Hutchinson Cancer Research Center, Seattle, WA, United States.

Funding

Systems Biology CoreU19AI128914 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Margaret Juliana McElrath, KENNETH D STUART · 2017 to 2026
$29.5M
Modeling the dynamics and evolution of immune responses to influenza virusesU19AI117891 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, ANTIA, RUSTOM NOSHIR · 2015 to 2019
$8.4M
Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathwaysR01AI138709 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OVERBAUGH, JULIE M. · 2018 to 2022
$5.0M
DEFINING THE INFANT IMMUNE RESPONSE TO HIVR01AI120961 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OVERBAUGH, JULIE M. · 2016 to 2020
$4.1M
Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptorsR01AI146028 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MATSEN, FREDERICK ALBERT · 2019 to 2024
$3.4M
Leveraing deep sequencing data to understand antibody maturationR01GM113246 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MATSEN, FREDERICK ALBERT · 2014 to 2018
$1.9M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI120961NIAID NIH HHS R01 AI138709NIAID NIH HHS R01 AI146028NIAID NIH HHS U19 AI117891NIAID NIH HHS U19 AI128914NIGMS NIH HHS R01 GM113246NIH HHS S10 OD020069
6 · The paper itself

Abstract

The adaptive immune system generates an incredible diversity of antigen receptors for B and T cells to keep dangerous pathogens at bay. The DNA sequences coding for these receptors arise by a complex recombination process followed by a series of productivity-based filters, as well as affinity maturation for B cells, giving considerable diversity to the circulating pool of receptor sequences. Although these datasets hold considerable promise for medical and public health applications, the complex structure of the resulting adaptive immune receptor repertoire sequencing (AIRR-seq) datasets makes analysis difficult. In this paper we introduce sumrep, an R package that efficiently performs a wide variety of repertoire summaries and comparisons, and show how sumrep can be used to perform model validation. We find that summaries vary in their ability to differentiate between datasets, although many are able to distinguish between covariates such as donor, timepoint, and cell type for BCR and TCR repertoires. We show that deletion and insertion lengths resulting from V(D)J recombination tend to be more discriminative characterizations of a repertoire than summaries that describe the amino acid composition of the CDR3 region. We also find that state-of-the-art generative models excel at recapitulating gene usage and recombination statistics in a given experimental repertoire, but struggle to capture many physiochemical properties of real repertoires.

Indexed as

Models, StatisticalReceptors, ImmunologicSoftwareData Interpretation, StatisticalHumansReceptors, ImmunologicB cell receptormodel validationrepertoire comparisonrep-seqsummary statisticsT cell receptor

Identifiers

PMID31736960
PMCPMC6838214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.